Pharmacological effects of SB 220025, a selective inhibitor of P38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples